Hjem › Fabrys sygdom
Fabrys sygdom kliniske forsøg rekrutterer i USA
10 studier for Fabrys sygdom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Atlanta, GA6 studier
- Arlington, VA6 studier
- Pittsburgh, PA4 studier
- Minneapolis, MN4 studier
- Cincinnati, OH4 studier
- Birmingham, AL4 studier
- New York City, NY3 studier
- Salt Lake City, UT3 studier
- Chicago, IL3 studier
- Cedar Rapids, IA3 studier
Efter delstat
- Alabama4 studier
- Georgia6 studier
- Illinois3 studier
- Iowa3 studier
- Minnesota4 studier
- New York4 studier
- Ohio4 studier
- Pennsylvania5 studier
- Utah3 studier
- Virginia6 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
RekruttererFase 1/2
Alder 18 til 65 · Mænd · Opdateret 24. sep. 2026 · NCT06270316A Study of Patients With Fabry Disease (US Specific)
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06906367A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 1. sep. 2026 · NCT06904261Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
RekruttererObservationsstudie
Alder 1 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT01581424A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
RekruttererFase 2/3
Alder 2 til 17 · Alle køn · Opdateret 10. aug. 2026 · NCT06328608Cardiovascular Multimodality Imaging Study
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06610019Fabry Disease Registry & Pregnancy Sub-registry
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 23. jun. 2026 · NCT00196742Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 19. mar. 2026 · NCT06941025A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. nov. 2025 · NCT06663358A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 8. jul. 2025 · NCT04252066Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.